pr-1319-s7mspmq-g3fvpqb3rlkzo.us-3.platformsh.site
Open in
urlscan Pro
52.137.90.183
Public Scan
Submitted URL: https://www.jandjventures.com.pr-1319-s7mspmq-g3fvpqb3rlkzo.us-3.platformsh.site/
Effective URL: https://pr-1319-s7mspmq-g3fvpqb3rlkzo.us-3.platformsh.site/venture-investing-jjdc/
Submission: On December 30 via api from US — Scanned from US
Effective URL: https://pr-1319-s7mspmq-g3fvpqb3rlkzo.us-3.platformsh.site/venture-investing-jjdc/
Submission: On December 30 via api from US — Scanned from US
Form analysis 1 forms found in the DOM
<form>
<div class="search-container">
<div class="content-input"><input type="text" placeholder="Enter Text" name="search" class="top-nav jj-light-gray" value=""></div>
<div class="content-box"><button type="submit" class=""></button>
<div class="fadingEffect"></div>
</div>
</div>
</form>Text Content
You need to enable JavaScript to run this app. Connect with UsSubscribe * Connect with Us * Subscribe * Our approach * Focus * How we partner * Our team * Innovation Challenges * News & events 1. Home 2. Venture Investing JJDC DRIVING INNOVATION THROUGH VENTURE INVESTING OverviewYear in ReviewTeamPartnershipNews JOHNSON & JOHNSON INNOVATION - JJDC, INC. (JJDC) IS THE STRATEGIC VENTURE CAPITAL ARM OF THE JOHNSON & JOHNSON FAMILY OF COMPANIES JJDC finds transformative ideas and helps them mature into potential solutions for todays patients. Guided by a clear, consistent investment strategy aligned with the scientific goals of Johnson & Johnson, JJDC works hand-in-hand with partners to help navigate the path to creating breakthrough health innovations. We invest across sectors—pharmaceuticals and medtech—and at all stages, from new company creation and seed-level startups to Series A and beyond, including private investments in public equity (PIPEs). Learn more about how we invest. All of our portfolio companies receive the same unwavering commitment to drive science and technology towards translation for patient benefit. We take a long-term approach, deploying the full capabilities of the Johnson & Johnson Family of Companies, including discovery, clinical development, regulatory affairs, manufacturing and commercialization. Our team includes leaders in the healthcare and technology communities, many with deep R&D experience. This gives us the ability to understand our partners and provide the help they need. Every opportunity is unique, with tailored roles and terms that provide the best path to potential success. JJDC YEAR IN REVIEW Learn more about JJDC's recent portfolio activity and strategic investments! Learn more MEET THE JJDC VENTURE INVESTING TEAM We are scientists, entrepreneurs, and innovators—here to make your next breakthrough possible. All team members <> slide 5 to 7 of 15 LIOR TEITELBAUM Senior Director, Venture Investments ANDRES TELLEZ Principal, New Company Creation WEI WU Senior Director, Venture Investments ASISH XAVIER Vice President, Venture Investments CHRIS PICARIELLO President, Johnson & Johnson Innovation – JJDC, Inc. GILAD GLICK Vice President, Venture Investments V. KADIR KADHIRESAN Vice President, Venture Investments EDNA LAZAR Principal, Venture Investments FIONA MACLAUGHLIN Principal, Venture Investments BIREN MEHTA Vice President, Venture Investments TAMIR MEIRI Principal, Venture Investments SANJAY MISTRY Vice President, Venture Investments New Company Creation MARIAN NAKADA Vice President, Venture Investments NANCY ONDOVIK Principal, Venture Investments & New Company Creation HIRAK PARIKH Principal, Venture Investments LIOR TEITELBAUM Senior Director, Venture Investments ANDRES TELLEZ Principal, New Company Creation WEI WU Senior Director, Venture Investments ASISH XAVIER Vice President, Venture Investments CHRIS PICARIELLO President, Johnson & Johnson Innovation – JJDC, Inc. GILAD GLICK Vice President, Venture Investments V. KADIR KADHIRESAN Vice President, Venture Investments EDNA LAZAR Principal, Venture Investments PARTNER SPOTLIGHT Accelerating innovation through strategic partnerships Reimagining Fibroblasts with Mestag Therapeutics Mestag Therapeutics, is a company founded in 2020 with the mission to develop impactful new medicines for patients by targeting discrete fibroblast sub-populations implicated in disease and to better understand how they influence immune cells. Learn more Rondo Therapeutics Learn more Moon Surgical Learn more Hangzhou DAC Biotechnology Co., Ltd. Learn more RELATED NEWS Hear from industry experts and explore the latest breakthroughs All news slide 5 to 7 of 30 Press Releases July 14, 2023 Astraveus raises €16.5 Million Series Seed round to advance the development of its automated, microfluidic Cell and Gene Therapy manufacturing platform Press Releases July 14, 2023 Moon Surgical Appoints Fred Moll, MD, as Board Chair and Raises Additional $55.4 Million in New Funding with Leading Investors Sofinnova Partners and NVIDIA Press Releases July 14, 2023 Solenic Medical, Inc. Announces $5.1M Series A Funding Round Led by Johnson & Johnson Innovation – JJDC, Inc. Webinar June 5, 2023 JLABS Info and Pitch Training Session Blog post November 26, 2024 The biotech start-up journey is a rollercoaster - enjoy the ride! Webinar November 26, 2024 Building a biotech: Launching and growing your start-up company Blog post November 18, 2024 Possible Investment in Life Sciences from New Sources Blog post September 24, 2024 Next-Gen Biotech Breakthrough Solutions, Next-Gen Innovation Hubs: Groundbreaking Partnerships at BioCentury Grand Rounds in Nashville Blog post September 24, 2024 Connecting investors with the life science startups in our ecosystem: Highlights from Johnson & Johnson at NewYorkBIO Innovation Summit Blog post September 19, 2024 Early-stage innovation in oncology – harnessing the unique strengths of EMEA Blog post September 19, 2024 JLABS SSF & Toronto Company Spotlight Press Releases September 16, 2024 J&J Leads Series D Financing in ONL Therapeutics to Protect Vision Webinar August 12, 2024 Biopharma deal and funding activity through Q2 and 2024 outlook Webinar August 8, 2024 Demystifying due diligence in biotech and medtech collaborations Blog post August 5, 2024 SSF JLABS Company Spotlight-Montara Therapeutics Press Releases July 11, 2024 Johnson & Johnson Invests in Refractive Technology Start-up TECLens Blog post June 25, 2024 Bridging investment networks for success Blog post May 29, 2024 My JLABS symposium top take-aways: Empowering startups in oncology innovation Blog post May 22, 2024 JLABS @ SSF Company Spotlight- Synlico Press Releases May 3, 2024 Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors Blog post May 1, 2024 SSF Company Spotlight-Tacit Blog post March 11, 2024 Driving early innovation in the Benelux through collaboration Press Releases February 8, 2024 Arkuda Therapeutics Announces Option and Asset Purchase Agreement Press Releases January 30, 2024 Accent Therapeutics Announces $75 Million Series C Financing to Advance Small Molecule Precision Cancer Therapies Blog post January 5, 2024 50 Years of Innovation: JJDC's Impactful Journey Press Releases December 13, 2023 Aro Biotherapeutics Secures $41.5M Series B Financing Press Releases December 13, 2023 Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovation – JJDC, Inc. Press Releases November 27, 2023 On Target Laboratories Secures $30 Million for Commercialization of CYTALUX® (pafolacianine) injection Press Releases September 22, 2023 ROME Therapeutics Closes Oversubscribed $72 Million Series B Extension to Support Advancement of Lead Program into Clinical Development for Autoimmune Disease Press Releases August 20, 2023 CirCode Biomed Closes Multi-Million-Dollar Series A Financing Press Releases July 14, 2023 Astraveus raises €16.5 Million Series Seed round to advance the development of its automated, microfluidic Cell and Gene Therapy manufacturing platform Press Releases July 14, 2023 Moon Surgical Appoints Fred Moll, MD, as Board Chair and Raises Additional $55.4 Million in New Funding with Leading Investors Sofinnova Partners and NVIDIA Press Releases July 14, 2023 Solenic Medical, Inc. Announces $5.1M Series A Funding Round Led by Johnson & Johnson Innovation – JJDC, Inc. Webinar June 5, 2023 JLABS Info and Pitch Training Session Blog post November 26, 2024 The biotech start-up journey is a rollercoaster - enjoy the ride! Webinar November 26, 2024 Building a biotech: Launching and growing your start-up company Blog post November 18, 2024 Possible Investment in Life Sciences from New Sources Blog post September 24, 2024 Next-Gen Biotech Breakthrough Solutions, Next-Gen Innovation Hubs: Groundbreaking Partnerships at BioCentury Grand Rounds in Nashville -------------------------------------------------------------------------------- <> STAY CONNECTED! Looking to learn more about incubation, collaboration or investment opportunities within the Johnson and Johnson Innovation network? Sign up for our newsletter to stay in touch! Subscribe * Approach * Early Innovation Partnerships * Venture Investing @ JJDC * Incubation @ JLABS * Late Stage Partnerships * Focus * MedTech * Pharmaceuticals * Cross-Sector Diversity, Equity & InclusionChallengesConnect with Us CareersLocationsSitemap Sign up to stay in touch with Johnson & Johnson Innovation Subscribe JNJInnovation JLABS JNJInnovationJLABS Apply JLABS Resident Login Visit our parent site Johnson & Johnson © Johnson & Johnson Innovation LLC 2024. All Rights Reserved. Your use of the information on this site is subject to the terms of our Legal Notice. Please see our Privacy Policy, Cookie Policy and Do Not Sell or Share My Information form. This site is published by Johnson & Johnson Innovation LLC which is solely responsible for its contents. This site is intended for global audiences. Capitalized product names are trademarks of the Johnson & Johnson Family of Companies or its affiliates. WE VALUE YOUR PRIVACY We want to give you the best experience, so we’d like to use cookies to tell us how to improve our site, keep things relevant for you and enable social media functions and ads. For more information (including data sharing with partners) or to adjust your preferences, see “Cookie Settings”. Click “Accept” if you agree or “Reject” to use only necessary cookies. Reject Accept Cookies Settings COOKIE PREFERENCE CENTER When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer. Allow All MANAGE CONSENT PREFERENCES STRICTLY NECESSARY COOKIES Always Active These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you, which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will then not work. Cookies Details FUNCTIONAL COOKIES Functional Cookies These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly. Cookies Details PERFORMANCE COOKIES Performance Cookies These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. You can set your browser to block or alert you about these cookies. Cookies Details MEDIA COOKIES Media Cookies These cookies are set by a range of media services that we have added to the site to enable the display of media content, such as embedded videos. Some of these cookies are necessary for the proper display of the media content. Some media services also place cookies that are capable of tracking your usage of the media service and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see such media services, such as videos. Please note that Google may automatically deploy YouTube cookies outside of our control. To find out how to manage Google and YouTube preferences and cookies, please visit https://policies.google.com/technologies/cookies#how-google-uses-cookies Cookies Details TARGETING COOKIES Targeting Cookies These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising. Cookies Details Back Button COOKIE LIST Search Icon Filter Icon Clear checkbox label label Apply Cancel Consent Leg.Interest checkbox label label checkbox label label checkbox label label Confirm My Choices